Certain pregnancy issues raise the chance of heart disease later in life. However, much more research is needed to understand how arteriosclerosis occurs between pregnancy and heart disease later in life.
According to the findings of a study published in the journal 'Circulation: Genomic and Precision Medicine', an entirely new field of tailored medicines for patients at risk of coronary heart disease could be determined from their genes.
Clinicians have traditionally treated cardiovascular disease by focusing on diabetes and blood pressure control, as well as lowering cholesterol with drugs such as aspirin and statins.